Kamika Jha

Kamika Jha is a managing director in the firm’s strategic advisory practice focused on healthcare.

Since joining Evercore in 2017, Ms. Jha has advised on a number of public and private healthcare companies and financial sponsors on mergers, acquisitions, sales and divestitures. Notable engagements include advising Blackstone on the sale of HealthEdge to Bain Capital, GE on its spinoff of GE Healthcare, TPG on its sale of Immucor to Werfen, Vocera on its sale to Stryker, Novo Nordisk on its acquisitions of Dicerna and Emisphere Technologies, GE on its acquisition of BK Medical, Biogen on its licensing transaction and acquisition of an equity stake in Denali Therapeutics, and Definitive Healthcare on its minority sale to Advent International.

Prior to joining Evercore, Ms. Jha was based in Singapore and was an associate manager with Julius Baer, and an analyst at Bank of America Merrill Lynch Wealth Management.

Ms. Jha graduated with honors with a B.A. in economics from Nanyang Technological University in Singapore and earned her MBA from University of Pennsylvania’s Wharton School.